Contents

Executive summary

Introduction & methodology

• Introduction
• Objectives and scope
• Methodology
• Abbreviations and definitions

Cutting-edge technology developments

• Introduction
• Innovations in end-use applications
• Value chain innovations
• Innovations in materials
• Innovations in 3D printing technology

3D printing in medical and pharmaceuticals by end use

• Introduction
• Medical devices
  •                 Anatomical models
  •                 Surgical instruments and fixation devices (orthoses)
  •                 Implantable and external prosthetics
  •                 Bioprinting of tissues and organs with live cells
• Drug formulations / Pharmaceuticals

Forecast development of the 3D printing medical and pharmaceutical value chain

• Introduction
• Supply chains – hype vs reality
• Regulations and liability
• Competitive landscape / key players
  •                 Suppliers of 3D printing machinery
  •                 Service bureaux
  •                 Manufacturers of 3D printed devices and drugs
  •                 Manufacturers of 3D printed drugs/pharmaceuticals      

3D printing market in medical and pharmaceuticals by material type

• Introduction
• Medical devices
  •                 Polymers
  •                 Metals / metal powders
  •                 Biomaterials / bioinks for bioprinting
  •                 Future outlook
• Drug formulations
  •                 Polymers and hydrogels as excipients
  •                 Future outlook

3D printing market in medical and pharmaceuticals by region

• Introduction
• North America
• Europe
• Asia-Pacific
• Rest of the world             

Executive Summary

• Global 3D printing market for medical and pharmaceuticals by end use 2017 – 27 by value ($ m)
• Global share of 3D printing market for medical and pharmaceuticals by region, 2017 – 27 by value ($ m)
• Pathways to innovations in 3D printing for medical and pharmaceuticals

Introduction & Methodology

• Important 3D manufacturing techniques
• definitions
• Abbreviations

Cutting Edge Technology Developments

• Pathways to innovations in 3D printing for medical and pharmaceuticals
• Innovations in end use applications
• Value chain innovations
• Innovations in materials
• Innovations in3D printing technologies
• Technology Transitions Table
• Future outlook, drivers and barriers to innovation & growth

3D Printing Markets by end use

• Global 3D printing market for medical and pharmaceuticals by end use 2017 – 27 by value and volume ($ m)
• Medical Devices 3D printing market by end use 2017 by value ($ m)
• Pharmaceuticals 3D printing market by end use 2027 by value ($ m)
• Key Milestones in 3D printing end-use applications in medical and pharmaceuticals
• Future outlook for 3D printed medical devices and pharmaceuticals

3D Printing Value Chains

• Key Regulations for 3D printed medical devices
• Key Regulations for 3D printed pharmaceuticals
• Key Players for 3D printed medical devices
• Key Players for 3D printed pharmaceuticals
• State-of-the-art in medical 3DP production 2017-27
• State-of-the-art in pharmaceuticals 3DP production 2017-27
• SWOT analysis of 3D printing equipment suppliers

3D Printing Market by material Types

• Global 3D printing raw materials market by type 2017-27, by value ($m)
• Global 3D printing raw materials market by type 2017-27, by volume  ‘000 tonnes)

3D Printing Market by Regions

• Global 3D printing market share by region, 2017-27, by value (%)
• Global 3D printing market by region, 2017-27, by value ($ m)
• North America 3D printing market by end use, 2017-27, by value ($ m)
• Europe 3D printing market by end use, 2017-27, by value ($ m)
• Asia-Pacific 3D printing market by end use, 2017-27, by value ($ m)
• Rest-of-the-world 3D printing market by end use, 2017-27, by value ($m)